Form 4: Whitehawk Therapeutics Insider Sells Shares
Statement of Changes in Beneficial Ownership
Bryan Ball, Chief Technical Operations Officer at Whitehawk Therapeutics, Inc., reported transactions involving the sale of company common stock.
Summary
- Bryan Ball, Chief Technical Operations Officer and SVP, Manufacturing Operations at Whitehawk Therapeutics, Inc., engaged in transactions involving the company's common stock.
- On April 9, 2026, 50,000 shares were sold at a price of $3.57 per share.
- On April 10, 2026, an additional 6,596 shares were sold at a price of $3.43 per share.
- These transactions were part of a broker-assisted sale to cover tax withholding obligations related to the vesting of restricted stock units.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral. While it involves the sale of shares by a key executive, the stated reason for the sale (tax withholding) is a common and expected event, rather than a reflection of negative sentiment towards the company's future performance.
Negatives
- Insider selling activity, particularly for tax withholding, can sometimes be interpreted negatively by the market, although it is a common practice.
Future Outlook
No specific future outlook or guidance is provided in this filing, as it pertains to insider transactions.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The sale of shares by an executive to cover tax obligations is a common occurrence and not necessarily indicative of a negative view on the company's prospects, but it does represent a reduction in insider ownership.
Stakeholder Impact
- Shareholders may note the reduction in beneficial ownership by a senior executive, though the reason for the sale is standard practice.
Key Dates
| Date | Description |
|---|---|
| 04/09/2026 | Earliest transaction date reported and date of sale of 50,000 shares. |
| 04/10/2026 | Date of sale of 6,596 shares. |
| 04/13/2026 | Date of signature for the filing. |
Keywords
Form 4, Insider Transaction, Whitehawk Therapeutics, Stock Sale, Restricted Stock Units, Tax Withholding, Bryan Ball
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.